Pharmafile Logo

Claire Long

- PMLiVE

Boehringer builds evidence base for its Humira biosimilar

Cyltezo shows clinical equivalence to AbbVie's blockbuster in a late-stage trial

Nobody knew healthcare was so complicated

short term and long term solutions

- PMLiVE

Abbott launches Bluetooth cardiac monitor Confirm RX in the US

The device sits under the patient’s skin and connects to the firm's myMerlin app

- PMLiVE

Global customer research in healthcare: 10 tips for capturing insights that matter

What makes a strong brand? One global core coupled with sensitivity to regions and countries. In part two of our series on customer insight and behaviour change, we share our...

Blue Latitude Health

dengue fever mosquito

Takeda dengue vaccine data looks good as it chases Sanofi

TAK-003 achieved a 71% reduction in developing the virus compared to placebo

How can pharma engage with the top performing STPs?

The recent announcement by Health Secretary Jeremy Hunt on which Sustainability and Transformation Partnerships (STPs) would benefit from a share of the £325m capital funding allocated in the Spring Budget,...

Wilmington Healthcare

Roche Basel Switzerland

Roche gets FDA OKs for Alecensa and Zelboraf

Gains US licences for first-line use in lung cancer and a rare blood cancer

- PMLiVE

Dr Jan van de Winkel joins Austrian biotech Hookipa

Joins the firm's board of directors, taking up the chairman's role

- PMLiVE

Apeiron bolsters management board

Peter Llewellyn-Davies joins as its CFO and CBO

The great schism

Technological advances in our industry are about to exacerbate societal inequality

Celgene building

Celgene gains French reimbursement for Revlimid in multiple myeloma

HAS decides it offers ' significant improvement' over existing treatments

- PMLiVE

Novartis files CAR-T therapy CTL109 in Europe

Analysts predict Kymriah could become a $1bn-plus product in Europe

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links